Germany's Boehringer Ingelheim has developed a once-daily pill that appears to increase sex drive in females. In the announcement on Monday, the company said that the drug, which is chemically flibanserin, increased sex drive in females with low libido.
In a Phase III study, the drug also increased the number of "satisfying sexual events" in over 2,000 pre-menopausal woman suffering from so-called Hypoactive Sexual Desire Disorder (HSDD).
"By modulating the neurotransmitter system, flibanserin may help to restore a balance between inhibitory and excitatory factors leading to a healthy sexual response," said researcher Elaine Jolly, a Canadian gynecologist. The drug is not without side effects though as one in seven participants experienced dizziness, nausea, sleepiness and insomnia.
As far as the timeframe for market release is concerned, Boehringer Chief Executive Andreas Barner told German magazine WirtschaftsWoche that the drug may be released in three years' time.